Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 20.61B P/E 38.99 EPS this Y 16.70% Ern Qtrly Grth 84.30%
Income 612.33M Forward P/E 17.18 EPS next Y 14.30% 50D Avg Chg 8.00%
Sales 8.12B PEG 1.38 EPS past 5Y 19.45% 200D Avg Chg 17.00%
Dividend N/A Price/Book 2.35 EPS next 5Y 14.23% 52W High Chg -3.00%
Recommedations 1.70 Quick Ratio 1.16 Shares Outstanding 82.50M 52W Low Chg 47.00%
Insider Own 0.66% ROA 3.83% Shares Float 81.31M Beta 1.16
Inst Own 101.37% ROE 6.90% Shares Shorted/Prior 1.39M/1.53M Price 251.51
Gross Margin 29.66% Profit Margin 7.54% Avg. Volume 779,072 Target Price 351.31
Oper. Margin 13.62% Earnings Date Apr 24 Volume 487,690 Change 0.91%
About ICON plc

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

ICON plc News
04/18/24 ICON (ICLR) Gains From New Offerings, Strategic Acquisitions
04/18/24 Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
04/17/24 Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
04/12/24 ICLR or CRL: Which Is the Better Value Stock Right Now?
04/03/24 ICON Announces CFO Transition
04/01/24 Recent Price Trend in Icon PLC (ICLR) is Your Friend, Here's Why
03/31/24 A Look At The Intrinsic Value Of ICON Public Limited Company (NASDAQ:ICLR)
03/29/24 ICON Public Limited Company (ICLR) Improved by 15% in Q4
03/25/24 ICON plc Schedules First Quarter 2024 Earnings Conference Call
03/22/24 ICON (ICLR) Up 7.6% Since Last Earnings Report: Can It Continue?
03/15/24 Icon PLC (ICLR) Is a Great Choice for 'Trend' Investors, Here's Why
03/14/24 ICLR vs. DOCS: Which Stock Is the Better Value Option?
03/14/24 ICON (NASDAQ:ICLR) shareholders have earned a 20% CAGR over the last five years
03/14/24 Zacks Industry Outlook Highlights Elevance Health, Cencora and ICON
03/13/24 3 Medical Services Stocks to Buy as Industry Trends Improve
03/04/24 ICON (ICLR) Gains From Strategic Deals, New Innovations
02/29/24 Are You Looking for a Top Momentum Pick? Why Icon PLC (ICLR) is a Great Choice
02/28/24 All You Need to Know About Icon PLC (ICLR) Rating Upgrade to Buy
02/26/24 ICON plc to Present at Upcoming Investor Conferences
02/24/24 Earnings Beat: ICON Public Limited Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
ICLR Chatroom

User Image Thestocktraderhubzee Posted - 2 weeks ago

WATCHLIST APR 05 2024. $SPWH B. Riley Securities Maintains Neutral on Sportsman's Warehouse, Lowers Price Target to $4 $ONCY Raymond James Initiates Coverage On Oncolytics Biotech with Outperform Rating, Announces Price Target of $3 $MXL Northland Capital Markets Upgrades MaxLinear to Outperform, Announces $30 Price Target $RIVN Morgan Stanley Maintains Overweight on Rivian Automotive, Lowers Price Target to $13 $ICLR Baird Maintains Outperform on Icon, Raises Price Target to $362

User Image OpenOutcrier Posted - 2 weeks ago

$ICLR (-1.3% pre) Icon Non-GAAP EPS of $3.46 beats by $0.01, revenue of $2.07B misses by $20M; announces departure of Brendan Brennan as CFO - SA https://ooc.bz/l/29454

User Image DonCorleone77 Posted - 2 weeks ago

$ICLR Icon backs FY24 adjusted EPS view $14.50-$15.30, consensus $14.94 Backs FY24 revenue view $8.4B-$8.8B, consensus $8.64B.

User Image Stock_Titan Posted - 2 weeks ago

$ICLR ICON Announces CFO Transition https://www.stocktitan.net/news/ICLR/icon-announces-cfo-6mmzgb2g9h2t.html

User Image Stock_Titan Posted - 03/25/24

$ICLR ICON plc Schedules First Quarter 2024 Earnings Conference Call https://www.stocktitan.net/news/ICLR/icon-plc-schedules-first-quarter-2024-earnings-conference-jra9hxi01uh8.html

User Image AnchorsAweigh Posted - 03/20/24

$ICLR getting tight

User Image StockInvest_us Posted - 1 month ago

Signal alert: $ICLR - Overbought Trend Short (Overvalued) https://stockinvest.us/l/XEmSlsVwMB

User Image swingingtech Posted - 1 month ago

$SCHR $ICLR $PFIE $FFHL https://wallstreetwaves.com/schr-etf-experiences-big-outflow/

User Image Stock_Titan Posted - 02/26/24

$ICLR ICON plc to Present at Upcoming Investor Conferences https://www.stocktitan.net/news/ICLR/icon-plc-to-present-at-upcoming-investor-w0nrz0i8otwz.html

User Image AnchorsAweigh Posted - 02/24/24

$CRL looks ready. Already got the move on $ICLR

User Image AnchorsAweigh Posted - 02/22/24

@Doozio YO 👁️ $ICLR

User Image AnchorsAweigh Posted - 02/22/24

$ICLR big winner

User Image swingingtech Posted - 02/21/24

$ICLR $CODX https://wallstreetwaves.com/icon-plc-iclr-q4-earnings-surpass-estimates/

User Image epsguid Posted - 02/21/24

$ICLR reported earnings of $3.46, consensus was $3.45, Earnings Whisper was $3.49 via @eWhispers #whispermiss http://eps.sh/d/iclr

User Image Stock_Titan Posted - 02/21/24

$ICLR ICON Reports Fourth Quarter and Full Year 2023 Results https://www.stocktitan.net/news/ICLR/icon-reports-fourth-quarter-and-full-year-2023-1rcynnoivybv.html

User Image AnchorsAweigh Posted - 2 months ago

@Doozio wow this entire sector is going. Check out $CRL $ICLR $MEDP (extended)

User Image Thai1 Posted - 2 months ago

$ICLR

User Image StockAutomatePro Posted - 01/22/24

$ICLR The chart suggests a bullish outlook for the stock. We alerted the BUY signal at $250 and we were able to close this one with profit at $265.21 🔏

User Image JRJR75 Posted - 2 months ago

@tellurider $ICLR right?

User Image StockAutomatePro Posted - 3 months ago

$ICLR Looks like the stock is about to take a nosedive based on the chart. We alerted the SELL signal at $275.19 and we were able to close this one with profit at $247.84 📊

User Image UltraAlgo Posted - 3 months ago

$ICLR Buy Rating from 5 signals, 15-min ticks 🚀 Chart by UltraAlgo https://i.redd.it/5mxcgjugukcc1.png

User Image StockAutomatePro Posted - 3 months ago

$ICLR The chart suggests a bearish outlook for the stock. We alerted the SELL signal at $277.53 and we were able to close this one with profit at $250.9 🥳

User Image DailyStocksPicks Posted - 3 months ago

My Oversold Stock Pick #3 Today: ICON plc ($ICLR) has faced challenges due to a five-year decline in earnings, despite notable revenue growth and a 53% increase in share price over five years, which has outperformed the market. While the stock has experienced a significant decline in the past year, its solid revenue growth and substantial operating cash flows present a mixed picture. Analysts have highlighted that ICON's stock trades at a premium compared to the sector, but there might still be room for growth based on the company's strong business fundamentals and growth operations​​​​​​. For more details https://youtu.be/Ar0PLu07G48

User Image DailyStocksPicks Posted - 3 months ago

My Oversold Stock Pick #3 Today: ICON plc ($ICLR) has also faced challenges due to a five-year decline in earnings, despite notable revenue growth and a 53% increase in share price over five years, which has outperformed the market. While the stock has experienced a significant decline in the past year, its solid revenue growth and substantial operating cash flows present a mixed picture. Analysts have highlighted that ICON's stock trades at a premium compared to the sector, but there might still be room for growth based on the company's strong business fundamentals and growth operations​​​​​​. For more details https://www.youtube.com/watch?v=vg5NnvXcaVA

User Image tickeron Posted - 3 months ago

If you’re trading this week, Read This! $ICLR RSI Indicator left the oversold zone. View odds of downtrend. https://srnk.us/go/4965963

User Image Pennzwoods Posted - 3 months ago

@mich1282 dough @semodough · 8h $ICLR survey of biotechs. In 60% of respondents said that they were looking to increase R&D budgets,with only 2% looking for budget reduction. 47% of respondents noted that the rising cost of capital will bear the biggest impact on its operations $XBI $IBB

User Image Pennzwoods Posted - 3 months ago

$TGTX Interesting side note from dough... $ICLR survey of biotechs. In 60% of respondents said that they were looking to increase R&D budgets,with only 2% looking for budget reduction. 47% of respondents noted that the rising cost of capital will bear the biggest impact on its operations $XBI $IBB

User Image EarningsInsider Posted - 3 months ago

$ICLR updates FY 2023 guidance to 12.630-12.910 EPS and revenue guidance to $8.1 billion-$8.2 billion. www.marketbeat.com/stocks/NASDAQ/ICL

User Image EarningsInsider Posted - 3 months ago

$ICLR updates FY 2024 guidance to 14.500-15.300 EPS and revenue guidance to $8.4 billion-$8.8 billion. www.marketbeat.com/stocks/NASDAQ/ICL

User Image EarningsInsider Posted - 3 months ago

$ICLR updates FY23 guidance to $12.63-12.91 EPS and revenue guidance to $8.07-8.21 billion. www.marketbeat.com/stocks/NASDAQ/ICLR/earnings/

Analyst Ratings
Baird Outperform Apr 4, 24
Mizuho Buy Apr 4, 24
Evercore ISI Group Outperform Feb 23, 24
Mizuho Buy Feb 23, 24
Barclays Overweight Feb 23, 24
Truist Securities Buy Feb 23, 24
Barclays Overweight Jan 25, 24
JP Morgan Overweight Dec 20, 23
Truist Securities Buy Dec 15, 23